Unlock stock picks and a broker-level newsfeed that powers Wall Street.

KOSDAQ - Delayed Quote KRW

BYON Co., Ltd. (032980.KQ)

Compare
302.00
0.00
(0.00%)
At close: February 27 at 3:30:28 PM GMT+9
Loading Chart for 032980.KQ
  • Previous Close 302.00
  • Open 0.00
  • Bid --
  • Ask --
  • Day's Range 302.00 - 302.00
  • 52 Week Range 196.00 - 1,303.00
  • Volume 0
  • Avg. Volume 5,205,372
  • Market Cap (intraday) 13.52B
  • Beta (5Y Monthly) 0.91
  • PE Ratio (TTM) --
  • EPS (TTM) --
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

BYON Co., Ltd. manufactures and sells industrial chemicals in South Korea and internationally. The company engages in the development of cell therapy using stem cell technology and commercialization of myocardial cells. The company also provides health functional food ingredients for pharmaceutical and food companies. In addition, it manufactures and sells cosmetics; and produces and distributes cosmetic containers and auxiliary materials. The company was formerly known as Polyvision Co., Ltd. BYON Co., Ltd. was founded in 1983 and is headquartered in Cheongju-si, South Korea.

by-on.co.kr/en/byon/

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 032980.KQ

View More

Performance Overview: 032980.KQ

Trailing total returns as of 4/10/2025, which may include dividends or other distributions. Benchmark is KOSPI Composite Index (^KS11) .

YTD Return

032980.KQ
47.02%
KOSPI Composite Index (^KS11)
1.90%

1-Year Return

032980.KQ
63.92%
KOSPI Composite Index (^KS11)
9.61%

3-Year Return

032980.KQ
80.96%
KOSPI Composite Index (^KS11)
9.46%

5-Year Return

032980.KQ
86.64%
KOSPI Composite Index (^KS11)
31.41%

Compare To: 032980.KQ

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 032980.KQ

View More

Valuation Measures

Annual
As of 4/9/2025
  • Market Cap

    13.52B

  • Enterprise Value

    59.33B

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.50

  • Price/Book (mrq)

    0.67

  • Enterprise Value/Revenue

    2.20

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -32.84%

  • Return on Assets (ttm)

    -9.36%

  • Return on Equity (ttm)

    -43.51%

  • Revenue (ttm)

    26.96B

  • Net Income Avi to Common (ttm)

    -8.85B

  • Diluted EPS (ttm)

    --

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    2.55B

  • Total Debt/Equity (mrq)

    178.31%

  • Levered Free Cash Flow (ttm)

    -7.41B

Research Analysis: 032980.KQ

View More

Company Insights: 032980.KQ

Research Reports: 032980.KQ

View More

People Also Watch

Waiting for permission
Allow microphone access to enable voice search

Try again.